Usual interstitial pneumonia

被引:42
作者
Lynch, Joseph P., III
Saggar, Rajan
Weigt, S. Sam
Zisman, David A.
White, Eric S.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm Crit Care Med & Hosp, Dept Internal Med, Los Angeles, CA 90095 USA
[2] Univ Michigan, Med Ctr, Div Pulm & Crit Care Med, Ann Arbor, MI USA
关键词
usual interstitial pneumonia (UIP); idiopathic pulmonary fibrosis (IPF); cryptogenic fibrosing alveolitis (CFA); fibroblast; fibroblastic foci; honeycombing;
D O I
10.1055/s-2006-957335
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Usual interstitial pneumonia (UIP) is a distinct histological lesion observed in idiopathic pulmonary fibrosis (IPF) but can be found in other etiologies. The diagnosis of UIP can be established by surgical lung biopsy or by high-resolution thin-section computed tomographic (CT) scans (provided the radiographic features are classical). Historically, patients labeled as "IPF" encompassed a group of disorders, including UIP as well as other idiopathic interstitial pneumonias that differ from UIP in prognosis and responsiveness to therapy. Current recommendations from international consensus statements restrict the term IPF to patients with idiopathic UIP. The inciting cause(s) and pathogenesis of UIP have not been elucidated, but alveolar epithelial cell injury and dysregulation or altered phenotypic expression of fibroblasts are key elements. Inflammatory cells may play minor roles in initiating or propagating the fibrotic process. The prognosis of UIP is poor. Mean survival following diagnosis approximates 3 years. Current therapies are of unproven value. Corticosteroids or immunosuppressive agents have been most often used, but data affirming benefit are lacking. Lung transplantation is a viable option for patients failing medical therapy. This review discusses diagnostic criteria for UIP (both histopathological and radiographic), natural history and clinical course, and therapeutic approaches (both current and future).
引用
收藏
页码:634 / 651
页数:18
相关论文
共 251 条
  • [1] Abraham J L, 1981, Chest, V80, P67
  • [2] CLINICAL AND FUNCTIONAL ASSESSMENT OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS - RESULTS OF A 3 YEAR FOLLOW-UP
    AGUSTI, C
    XAUBET, A
    AGUSTI, AGN
    ROCA, J
    RAMIREZ, J
    RODRIGUEZROISIN, R
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (04) : 643 - 650
  • [3] Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis
    Akira, M
    Kozuka, T
    Inoue, Y
    Sakatani, M
    [J]. CHEST, 2005, 127 (01) : 185 - 191
  • [4] CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis
    Akira, M
    Hamada, H
    Sakatani, M
    Kobayashi, C
    Nishioka, M
    Yamamoto, S
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (01) : 79 - 83
  • [5] IDIOPATHIC PULMONARY FIBROSIS - PROGRESSION OF HONEYCOMBING AT THIN-SECTION CT
    AKIRA, M
    SAKATANI, M
    UEDA, E
    [J]. RADIOLOGY, 1993, 189 (03) : 687 - 691
  • [6] Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703
  • [7] [Anonymous], 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]
  • [8] [Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
  • [9] Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
    Arase, Y
    Ikeda, K
    Tsubota, A
    Saitoh, S
    Suzuki, Y
    Kobayashi, M
    Suzuki, F
    Someya, T
    Akuta, N
    Hosaka, T
    Kobayashi, M
    Kumada, H
    [J]. HEPATOLOGY RESEARCH, 2003, 27 (02) : 89 - 94
  • [10] Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
    Arcasoy, SM
    Christie, JD
    Ferrari, VA
    Sutton, MS
    Zisman, DA
    Blumenthal, NP
    Pochettino, A
    Kotloff, RM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) : 735 - 740